Dr. Tami D Lieberman's lab at MIT studies how the human microbiome evolves and adapts over time, focusing on the changes in bacterial populations that occur within individual people. They explore the factors that influence these changes and how it affects health, particularly in response to urban lifestyles. The ultimate goal is to enhance microbiome-targeted therapies by understanding these complex interactions.

Dr. Emily R. Liman's research lab focuses on understanding how taste receptors in mammals detect different tastes, particularly sour and salty flavors. The lab studies a specific channel called OTOP1, which plays a crucial role in sensing acids and high concentrations of salts. By exploring how OTOP1 functions, the research aims to develop new tools to enhance our understanding of taste and potentially improve dietary choices to help combat health issues like obesity and hypertension.

Jessica L. Whited's lab at Harvard University focuses on understanding how axolotls can completely regenerate their limbs after amputation. They explore the systemic responses activated during this process, providing insights that could eventually lead to better regenerative medicine solutions for humans. By studying the interaction between the central nervous system and tissue regeneration, the lab aims to unravel the complex mechanisms behind successful limb repair and regeneration.

Dr. Hui-Kuan Lin's lab at Duke University focuses on understanding cancer, particularly non-small cell lung cancer (NSCLC) and prostate cancer. The research aims to identify cancer stem cells and their roles in cancer progression and treatment resistance. By developing novel therapeutic strategies that target these unique cell populations, the lab aims to improve treatment outcomes for patients with advanced-stage cancers.

Zhen Lin's lab at Tulane University focuses on understanding the Epstein-Barr virus (EBV) and its role in various diseases, particularly in patients with HIV/AIDS. They investigate how EBV switches between dormancy and active replication, and how this process can lead to cancer and autoimmune diseases. A significant aspect of their research is exploring newly discovered types of RNAs, called alpha-satellite RNAs, that may play crucial roles in EBV's viral lifecycle and its interaction with host cells.

Dr. John Lacava's research lab focuses on understanding the role of LINE-1 retrotransposons in neurodegenerative diseases like Alzheimer's Disease and related dementias. By investigating how these genetic elements contribute to cellular aging and inflammation, the lab aims to uncover potential mechanisms behind the onset of these diseases. Through various experimental approaches, including examining biological samples from patients and cell cultures, the lab seeks to clarify the relationship between LINE-1 and cellular senescence, ultimately hoping to inform strategies for better understanding and treating these conditions.

Dr. Christopher G. Burd's lab at Yale University focuses on understanding how lipids are distributed and modified in different parts of the cell, particularly in the Golgi apparatus. By studying these processes, the lab aims to uncover new insights into how cells regulate their internal environment, which can be crucial for understanding various diseases, including cancer and neurodegenerative disorders like Alzheimer's. The research has implications for improving our knowledge of cell function and potential therapeutic targets.

Dr. Bo Wang's lab focuses on understanding how certain proteins in liver cells influence the metabolism of lipids, specifically cholesterol and triglycerides. This research is essential for tackling cardiovascular diseases like atherosclerosis, which is linked to high levels of these lipids in the blood. By studying the role of the SEC16B protein, the lab aims to identify new therapeutic targets that could help reduce the risk of developing heart-related health issues.

Dr. Shi-He Liu's lab at the University of Toledo focuses on developing advanced delivery systems for targeted cancer therapies, especially for pancreatic cancer. They are engineering exosomes, which are tiny vesicles that can carry drugs or genes to specific cells. The goal is to improve the accuracy and effectiveness of cancer treatments while reducing side effects. Their innovative approaches may lead to significant breakthroughs in cancer medicine.

Dr. Ta-Chiang Liu's lab focuses on understanding how HIV impacts gut health and the role of diet in gut immunity. They use advanced mouse models and cell culture techniques to study gut inflammation and the functions of special cells called Paneth cells, which are crucial for intestinal health. Their goal is to uncover mechanisms that contribute to gut dysfunction in people with HIV and those with obesity-related issues, ultimately aiding in the development of new treatments.

Dr. Erfei Bi's lab at the University of Pennsylvania focuses on understanding how liver cells (hepatocytes) organize themselves and how they divide. The research aims to explore the formation of bile canaliculi, which are essential for liver function and can impact liver diseases. Additionally, the lab investigates the cytoskeleton's role in cell division, which has implications for various diseases, including cancers and neurodegenerative disorders.

Dr. Jason K. Kim's lab focuses on understanding how insulin resistance and inflammation in the liver are linked to Alzheimer's disease. They research the roles of immune cells and inflammatory signals on brain health, exploring how these factors influence cognitive decline in aging individuals. Their findings aim to uncover potential new treatments for Alzheimer's and related neurodegenerative diseases.

Dr. Margaret S. Livingstone's lab at Harvard Medical School studies how early visual experiences shape the brain's ability to recognize different types of objects, such as faces and places. By manipulating visual input during critical development periods, the lab investigates the lasting effects on neuronal circuits involved in object recognition. Understanding these processes can help address issues like amblyopia and improve therapies for visual processing disorders.

Dr. Wan-Lin Lo's lab at the University of Utah focuses on understanding how CD7 signaling affects T cells, which are crucial for our immune response. The lab studies how CD7 influences T cell activation and differentiation, especially during infections and diseases like cancer and autoimmune disorders. By uncovering the roles of CD7, they aim to develop new therapies that could enhance T cell responses or prevent them from becoming exhausted during chronic conditions.

David M Lonard's research lab focuses on understanding how sex hormones, particularly androgens and progesterone, influence reproductive biology at the molecular level. Using advanced techniques like cryo-electron microscopy, the lab investigates how hormone receptors interact with coregulators and DNA to regulate gene expression. Their work aims to reveal the structural mechanisms behind male and female reproductive processes, potentially addressing issues like infertility and reproductive disorders.

Dr. Damaris N Lorenzo's lab focuses on understanding how II-spectrin, a crucial protein in the neuronal cytoskeleton, contributes to brain development and function, particularly in the cerebellum. Their research investigates the mechanisms behind neurodevelopmental disorders linked to mutations in the SPTBN1 gene, which can lead to developmental delays and other cognitive challenges. By employing a range of techniques from microscopy to behavioral analysis, the lab aims to uncover the cellular pathways affected by II-spectrin and how these relate to various neurological conditions.

Dr. Christian L. Lorson's lab focuses on developing gene therapies for inherited neurological disorders, particularly Charcot-Marie-Tooth disease and related conditions. The lab works on creating animal models that mimic human diseases to understand the biological processes involved and to test potential therapeutic approaches. Ultimately, the goal is to develop effective treatments that can improve the quality of life for affected individuals.

Dr. Priscila Falagan Lotsch's lab at Auburn University studies how engineered nanomaterials (ENMs) affect human health, focusing specifically on their impact on mitochondria, the powerhouses of our cells. By investigating how these materials influence mitochondrial function under real-world exposure scenarios, the lab seeks to understand both the potential risks and benefits associated with nanotechnology. This research is crucial for developing safer nanotechnologies and therapeutic strategies to combat chronic diseases.

Dr. Yong Lu's lab focuses on understanding how certain proteins in the brain influence the development of auditory pathways critical for sound localization. By studying the role of the metabotropic glutamate receptor 5 (mGluR5), the lab aims to uncover how disruptions in this protein can affect hearing and brain development. This research is important for developing treatments for auditory processing disorders and improving our understanding of hearing mechanisms.

Dr. Bingwei Lu's lab at Stanford University explores the connections between tau protein abnormalities and mitochondrial dysfunction in neurodegenerative diseases like Alzheimer's and Parkinson's. By understanding how these factors interact, the lab aims to develop new therapeutic strategies to combat a variety of brain disorders. The research combines molecular genetics, biochemistry, and cell biology techniques to uncover the mechanisms underlying these diseases.